thymosin beta-4 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-11-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
== Time of maximum daughter activity == In transient equilibrium, the daughter activity increases and eventually reaches a maximum value that can exceed the parent activity. The time of maximum activity is given by:
=== Spring 1945 offensive in Italy === Kesselring's forces in Italy retained their formidable defensive positions in the northern Apennines in March 1945. The 6th Division rejoined the line in early April, shortly before the Allies launched their spring 1945 offensive, Operation Grapeshot. The units including Rhodesians took up positions opposite Monte Sole, Monte Abelle and Monte Caprara. The Rhodesian 25-pounder guns were posted slightly forward of their former positions, and B (Rhodesia) Squadron, Prince Alfred's Guard, moved to Grizzana. The Special Service Battalion provided armoured support to the 13th South African Motorised Brigade. The South Africans and Rhodesians launched a two-pronged assault on the German positions over the road to Bologna at 22:30 on 15 April 1945. The Cape Town Highlanders' advance up the steep cliffs of Monte Sole was obstructed by a German minefield that guarded the peak. The Rhodesian officer commanding the leading platoon, Second Lieutenant G B Mollett, took a section of men and dashed through the minefield to the summit; for this he later received the Distinguished Service Order. Hand-to-hand fighting on Monte Sole continued until dawn, when the Germans withdrew. The Witwatersrand Rifles meanwhile took Monte Caprara. The Cape Town Highlanders took Monte Abelle late on 16 April, advancing under heavy artillery fire to the summit before clearing it of Germans. The regiment lost 31 killed and 76 wounded during these actions, including three Rhodesians killed and three wounded.
== Treatment == The management of lipodermatosclerosis may include treating venous insufficiency with leg elevation and elastic compression stockings. In some difficult cases, the condition may be improved with the additional use of the fibrinolytic agent, stanozol. Fibrinolytic agents use an enzymatic action to help dissolve blood clots. Stanozol is injected directly into the affected area. Venous Ablation has also been known to help circulation in patients. Lifestyle changes such as maintaining a healthy weight & diet, exercising regularly, avoiding prolonged sitting or standing, and elevating your legs can play a significant role in managing lipodermatosclerosis and reducing its symptoms.
3 NH4SCN → 2 CH5N3 + H2S + CS2 The commercial route involves a two step process starting with the reaction of dicyandiamide with ammonium salts. Via the intermediacy of biguanidine, this ammonolysis step affords salts of the guanidinium cation (see below). In the second step, the salt is treated with base, such as sodium methoxide. Isothiouronium salts (S-alkylated thioureas) react with amines to give guanidinium salts:
Member of Parliament refers to elected members of the Parliament of Singapore, the appointed Non-constituency Member of Parliament from the opposition, as well as the Nominated Members of Parliament, who may be appointed from members of the public who have no connection to any political party in Singapore.
Sources: en.wikipedia.org
In immunology, the mononuclear phagocyte system or mononuclear phagocytic system (MPS), also known as the macrophage system, is a part of the immune system that consists of the phagocytic cells located in reticular connective tissue. The cells are primarily monocytes and macrophages, and they accumulate in lymph nodes and the spleen. The Kupffer cells of the liver and tissue histiocytes are also part of the MPS. The mononuclear phagocyte system and the monocyte macrophage system refer to two different entities, often mistakenly understood as one. "Reticuloendothelial system" is an older term for the mononuclear phagocyte system, but it is used less commonly now, as it is understood that most endothelial cells are not macrophages. The mononuclear phagocyte system is also a somewhat dated concept trying to combine a broad range of cells, and should be used with caution.
== External links == Allozyme Electrophoresis Techniques – a complete guide to starch gel electrophoresis Development of new isozyme specific therapeutics – Fatty Acid Dioxygenases and Eicosanoid Hormones (Estonia)
Full fat cottage cheese is 78% water, 12% protein, 5% carbohydrates, and 4% fat (table). In a reference amount of 100 g (3.5 oz), full fat cottage cheese supplies 103 calories of food energy, and is a rich source (20% or more of the Daily Value, DV) of vitamin B12 (28% DV) and a moderate source of phosphorus and sodium (12-15% DV, table). Cottage cheese is safe to eat during pregnancy, unlike some cheese products that are not recommended. Other than supplying nutrients, there is little evidence that consuming cottage cheese provides any direct health effects.
=== Zwitterion === Zwitterions contain an anionic and a cationic centre in the same molecule, but are not considered salts. Examples of zwitterions are amino acids, many metabolites, peptides, and proteins.
On 4–11 February 1945 leaders from the United States, the United Kingdom, and the Soviet Union held the Yalta Conference where future arrangements regarding post-war Europe and Allied strategy against Japan in the Pacific were negotiated. They agreed that the boundaries of Germany as at 31 December 1937 would be chosen as demarcating German national territory from German-occupied territory; all German annexations after 1937 were automatically null. Subsequently, and into the 1970s, the West German state was to maintain that these 1937 boundaries continued to be 'valid in international law', although the Allies had already agreed amongst themselves that the territories east of the Oder–Neisse line must be transferred to Poland and the Soviet Union in any peace agreement. The conference agreed that post-war Germany, minus these transfers, would be divided into four occupation zones: a French Zone in the far west; a British Zone in the northwest; an American Zone in the south; and a Soviet Zone in the East. Berlin was separately divided into four zones. These divisions were not intended to dismember Germany, only to designate zones of administration.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.